HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michelle Lockley Selected Research

Interleukin-6 (Interleukin 6)

3/2011Inhibition of the inflammatory cytokine TNF-α increases adenovirus activity in ovarian cancer via modulation of cIAP1/2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michelle Lockley Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 09/2006
12Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 01/2006
10Carcinoma (Carcinomatosis)
04/2021 - 01/2006
3Teratoma (Teratoid Tumor)
04/2022 - 01/2020
3Neoplasm Metastasis (Metastasis)
01/2018 - 01/2016
3Infections
01/2016 - 03/2011
2Inflammation (Inflammations)
01/2016 - 07/2015
1Seminoma
01/2022
1Pulmonary Embolism
11/2021
1Venous Thromboembolism
11/2021
1Ovarian Epithelial Carcinoma
01/2021
1Kidney Neoplasms (Kidney Cancer)
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
01/2018
1Disease Progression
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Tertiary Lymphoid Structures
10/2016
1Ascites
07/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2012
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2011

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
02/2019 - 07/2010
4CytokinesIBA
01/2022 - 03/2011
2Carboplatin (JM8)FDA LinkGeneric
01/2022 - 01/2021
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 04/2015
2PlatinumIBA
01/2021 - 01/2021
2AntigensIBA
01/2021 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2011
2dl1520 (ONYX-015)IBA
04/2015 - 01/2006
1ArrestinsIBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Carvedilol (Coreg)FDA LinkGeneric
01/2022
1Cell-Free Nucleic AcidsIBA
08/2021
1chloroxineFDA Link
01/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1Pharmaceutical PreparationsIBA
01/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1Antigen-Antibody Complex (Immune Complex)IBA
01/2017
1rucaparibIBA
10/2016
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1IntegrinsIBA
07/2015
1cyclic arginine-glycine-aspartic acid peptideIBA
07/2015
1Junctional Adhesion Molecule CIBA
10/2013
1Dihydrotachysterol (AT 10)IBA
10/2013
1Messenger RNA (mRNA)IBA
09/2012
1Checkpoint Kinase 1IBA
04/2011
1Infliximab (Remicade)FDA Link
03/2011
1Interleukin-6 (Interleukin 6)IBA
03/2011
1thymidine kinase 1IBA
09/2006
1alovudineIBA
09/2006
1Renilla LuciferasesIBA
09/2006
1Icodextrin (Extraneal)FDA Link
01/2006
1LuciferasesIBA
01/2006
1Viral ProteinsIBA
01/2006

Therapy/Procedure

9Drug Therapy (Chemotherapy)
04/2021 - 04/2015
6Therapeutics
01/2022 - 01/2014
6Neoadjuvant Therapy
11/2021 - 08/2015
2Cytoreduction Surgical Procedures
11/2021 - 01/2021
2Adjuvant Chemotherapy
01/2021 - 01/2020
1Salpingo-oophorectomy
04/2022
1Cystectomy
04/2022
1Combination Drug Therapy (Combination Chemotherapy)
01/2022
1Radiotherapy
01/2022
1Vena Cava Filters (Inferior Vena Cava Filter)
11/2021
1Treatment Delay
11/2021